JP2022551067A5 - - Google Patents
Info
- Publication number
- JP2022551067A5 JP2022551067A5 JP2022520063A JP2022520063A JP2022551067A5 JP 2022551067 A5 JP2022551067 A5 JP 2022551067A5 JP 2022520063 A JP2022520063 A JP 2022520063A JP 2022520063 A JP2022520063 A JP 2022520063A JP 2022551067 A5 JP2022551067 A5 JP 2022551067A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- hydroxy
- benzo
- pentyl
- chromen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962909370P | 2019-10-02 | 2019-10-02 | |
| US62/909,370 | 2019-10-02 | ||
| PCT/CA2020/051328 WO2021062557A1 (en) | 2019-10-02 | 2020-10-02 | Cannabinoid derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022551067A JP2022551067A (ja) | 2022-12-07 |
| JP2022551067A5 true JP2022551067A5 (enExample) | 2023-10-11 |
Family
ID=75336679
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022520063A Pending JP2022551067A (ja) | 2019-10-02 | 2020-10-02 | カンナビノイド誘導体 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20220340582A1 (enExample) |
| EP (1) | EP4038058A4 (enExample) |
| JP (1) | JP2022551067A (enExample) |
| WO (1) | WO2021062557A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021007663A1 (en) | 2019-07-12 | 2021-01-21 | Canopy Growth Corporation | Cannabinoid derivatives |
| JP2022540586A (ja) | 2019-07-12 | 2022-09-16 | キャノピー グロウス コーポレイション | カンナビノイド誘導体 |
| US12252503B2 (en) | 2019-07-12 | 2025-03-18 | Canopy Growth Corporation | Cannabinoid derivatives |
| JP2022551066A (ja) | 2019-10-02 | 2022-12-07 | キャノピー グロウス コーポレイション | カンナビノイド誘導体 |
| WO2021102567A1 (en) | 2019-11-26 | 2021-06-03 | Canopy Growth Corporation | Cannabigerol derivatives and use thereof as cannabinoid receptor modulators |
| US12240813B2 (en) | 2020-05-19 | 2025-03-04 | Cybin Irl Limited | Deuterated tryptamine derivatives and methods of use |
| CA3205594A1 (en) | 2020-12-17 | 2022-06-23 | Nalu Bio, Inc. | Synthesis of cannabidiol and analogs thereof, and related compounds, formulations, and methods of use |
| US12091396B1 (en) * | 2021-10-07 | 2024-09-17 | Adam Woodson | System and method for reacting one or more compounds to form tetrahydrocannabinolic acid (THCA) |
| US20250019345A1 (en) * | 2021-11-10 | 2025-01-16 | London Pharmaceuticals And Research Corporation | New cannabinoid-gabapentinoid conjugates and uses thereof |
| KR102634945B1 (ko) * | 2021-11-16 | 2024-02-08 | (주)케이메디켐 | 신규한 카나비크로멘산 유도체, 이의 제조방법 및 이를 포함하는 인지기능 개선용 조성물 |
| WO2024192324A2 (en) * | 2023-03-15 | 2024-09-19 | Berkowitz Barry A | Analogs of cannabichromene and cannabichromenic acid and process of preparing |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006012176A1 (en) * | 2004-06-24 | 2006-02-02 | Virginia Commonwealth University | Water-soluble cannabinoids |
| WO2014039042A1 (en) * | 2012-09-06 | 2014-03-13 | Northeastern University | Novel cannabinergic compounds and uses thereof |
| WO2014134127A1 (en) * | 2013-02-26 | 2014-09-04 | Northeastern University | Cannabinergic nitrate esters and related analogs |
| WO2019234728A1 (en) * | 2018-06-04 | 2019-12-12 | Al&Am Pharmachem Ltd. | Cannabinolic acid derivatives and uses thereof |
| WO2021007659A1 (en) * | 2019-07-12 | 2021-01-21 | Canopy Growth Corporation | Cannabinoid derivatives |
-
2020
- 2020-10-02 WO PCT/CA2020/051328 patent/WO2021062557A1/en not_active Ceased
- 2020-10-02 US US17/765,853 patent/US20220340582A1/en active Pending
- 2020-10-02 EP EP20872491.4A patent/EP4038058A4/en active Pending
- 2020-10-02 JP JP2022520063A patent/JP2022551067A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022551067A5 (enExample) | ||
| JP2022551066A5 (enExample) | ||
| JP2022539400A5 (enExample) | ||
| JP2022540434A5 (enExample) | ||
| JP2023503330A5 (enExample) | ||
| JP2022540432A5 (enExample) | ||
| JP2022539401A5 (enExample) | ||
| US8501814B2 (en) | Selective androgen receptor modulators | |
| EP3302471B1 (en) | Tetrasubstituted alkene compounds and their use | |
| JP2022540585A5 (enExample) | ||
| ES2590929T3 (es) | Derivados de bencilsulfonamida útiles como inhibidores de MOGAT-2 | |
| JP2022540586A5 (enExample) | ||
| ES2960991T3 (es) | Benzoimidazol-1,2-ilamidas como activadores del canal Kv7 | |
| JP2023503331A5 (enExample) | ||
| JP2024533216A (ja) | インドール化合物及び使用方法 | |
| AR074184A1 (es) | Compuestos de 7-azaspiro[3.5]nonano-7-carboxamida, composiciones farmaceuticas que los comprenden y su uso en la fabricacion de medicamentos para el tratamiento de afecciones mediadas por la inhibicion de faah | |
| IL287159B2 (en) | Small molecules agonists for FXR (farnesoid X receptor) and method for their preparation and use | |
| JP2022540433A5 (enExample) | ||
| EP2161997A1 (en) | Tricyclic inhibitors of fatty acid amide hydrolase | |
| JP2010533645A5 (enExample) | ||
| JP2011500818A5 (enExample) | ||
| AU2013215549B2 (en) | Novel morpholinyl derivatives useful as MOGAT-2 inhibitors | |
| JP2010509334A5 (enExample) | ||
| JP2008543874A5 (enExample) | ||
| JP2011511053A (ja) | ボリノスタットの新規な製造方法 |